NAT8L
N-acetylaspartate synthetase
Also known as: FLJ37478, Hcml3, NAT8L_HUMAN, Shati
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N9F0
- Gene
- NAT8L
- Ensembl
- ENSG00000185818
- Chromosome
- 4
- Canonical length
- 302 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a single-pass membrane protein, which contains a conserved sequence of the GCN5 or NAT superfamily of N-acetyltransferases and is a member of the N-acyltransferase (NAT) superfamily. This protein is a neuron-specific protein and is the N-acetylaspartate (NAA) biosynthetic enzyme, catalyzing the NAA synthesis from L-aspartate and acetyl-CoA. NAA is a major storage and transport form of acetyl coenzyme A specific to the nervous system. The gene mutation results in primary NAA deficiency (hypoacetylaspartia). [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
302 residues, UniProt reviewed canonical sequence.
>Q8N9F0|NAT8L
1 MHCGPPDMVC ETKIVAAEDH EALPGAKKDA LLAAAGAMWP PLPAAPGPAA APPAPPPAPV
61 AQPHGGAGGA GPPGGRGVCI REFRAAEQEA ARRIFYDGIM ERIPNTAFRG LRQHPRAQLL
121 YALLAALCFA VSRSLLLTCL VPAALLGLRY YYSRKVIRAY LECALHTDMA DIEQYYMKPP
181 GSCFWVAVLD GNVVGIVAAR AHEEDNTVEL LRMSVDSRFR GKGIAKALGR KVLEFAVVHN
241 YSAVVLGTTA VKVAAHKLYE SLGFRHMGAS DHYVLPGMTL SLAERLFFQV RYHRYRLQLR
301 EELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAT8L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 93 nTPM
- basal ganglia: 77 nTPM
- amygdala: 66 nTPM
- hippocampal formation: 58 nTPM
- cerebellum: 46 nTPM
- midbrain: 43 nTPM
Single-cell type
- astrocytes: 173 nCPM
- pituicytes/fscs: 96 nCPM
- ependymal cells: 67 nCPM
- retinal horizontal cells: 50 nCPM
- bergmann glia: 47 nCPM
- oligodendrocyte progenitor cells: 40 nCPM
Immune cell
- plasmacytoid DC: 0.9 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 265 nTPM
- thalamus: 251 nTPM
- pons: 186 nTPM
- amygdala: 179 nTPM
- medulla oblongata: 172 nTPM
- midbrain: 161 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NAT8L.
Disease | AllUniProt
Conditions NAT8L is implicated in, by any mechanism.
- N-acetylaspartate deficiency (NACED) MIM:614063
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.86
- gnomAD missense Z
- 2.15
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- L-aspartate N-acetyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAT8L as an antibody target. Whether an autoantibody or antibody against NAT8L could matter depends on whether native NAT8L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAT8L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NAT8L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...